NIFTY PHARMA index recorded a loss of 2.87% for the week. Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories and Divi’s ...

The company’s net profit came in at ₹148.30 Crore. In the year-ago period, the business reported a net profit of ₹141.80 ...

The company said that its board accorded approval for sub-division of one equity share of ₹10 each face value.

WHY EQUITY SAVINGS FUNDS? Equity savings funds combine pure equity, debt, and arbitrage positions (cash-futures). This ...

Larsen & Toubro (L&T) has announced that its renewables division has bagged a significant EPC contract. The project involves ...

The agreement outlines a 10-year arrangement under which HPCL will import liquefied natural gas to meet part of its long-term ...

FPI flows remained under pressure as the uncertainty over tariffs and the Indo-US trade deal kept markets in check ...

Domestic sales also edged up, with the company dispatching 13,501 units in July. This marked a 4% growth over the previous ...

Total impairment costs rose sharply to ₹192 crore during the quarter, up from ₹87 crore in the same period last year.

Revenue climbs 64.4% year-on-year to ₹529.3 crore up from ₹322 crore in the corresponding period of the previous fiscal ...

JK Lakshmi Cement's revenue for the quarter came in at ₹1,763.14 crore, an increase of nearly 12% over the same period last ...

The book-running lead managers to the issue are IIFL Capital Services, IDBI Capital Markets & Securities, and JM Financial.